David Rutley MP welcomed the announcement that £20 million funding has been secured for the Cheshire-Greater Manchester Life Sciences Investment Fund.
The Life Science Investment Fund is part of the Cheshire & Warrington Growth Deal, which aims to continue to drive growth in our area in the years ahead. The Fund will support growth in life sciences at the Alderley Park science park site and beyond. It will also be instrumental in encouraging new start ups and spin-outs, following AstraZeneca’s decision to move its research and development facilities to Cambridge.
As a member of the Alderley Park Task Force, David has been actively working with the Cheshire & Warrington Enterprise Partnership, Cheshire East Council and Government Ministers to secure this important funding. This initiative is seen as a critical priority, which builds on the life science heritage in North-East Cheshire and Greater Manchester.
“I am delighted to learn about the creation of the Cheshire-Greater Manchester Life Science Investment Fund. The £20 million pledged in the Growth Deal will help build on the strong science skills base in and around Macclesfield. It will also help establish a sustainable future at the Alderley Park science park and provide support to new innovative schemes. The Investment Fund is great news for our area.”